Rigel Pharmaceuticals
RIGL
RIGL
95 hedge funds and large institutions have $300M invested in Rigel Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 33 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 33
Holders
95
Holding in Top 10
1
Calls
$1.1M
Puts
$531K
Top Buyers
| 1 | +$8.46M | |
| 2 | +$4.81M | |
| 3 | +$3.89M | |
| 4 |
BC
Broadfin Capital
New York
|
+$1.85M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$1.79M |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$8.77M | |
| 3 | -$5.88M | |
| 4 |
MG
Meditor Group
Hamilton,
Bermuda
|
-$3.01M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$2.76M |